ExonHit may also obtain potential EHT/AGN 0001 related advancement – and regulatory-based milestone payments exceeding USD $32 million and royalties on future world-wide sales. The potency of the license contract between Bristol-Myers Squibb and Allergan is subject to antitrust clearance by the U.S. Federal government Trade Section and Commission of Justice under the provisions of the Hart-Scott-Rodino Antitrust Improvements Take action of 1976, and additional customary regulatory approvals. ExonHit will continue its collaboration with Allergan on additional compounds.Jing Lou, Chief Executive Officer of 3SBio Inc. SOURCE 3SBio Inc.

A*STAR IDA and IHPC sign up for to build up world-class cloud computing-powered technological solutions to benefit local ICT companies Cloud solutions to accelerate local ICT companies' adoption of technologies and overcome end-user problems confronted by the ICT industry A*Celebrity's Institute of High Performance Processing and the Infocomm Advancement Authority of Singapore inked an agreement on the 28th of August to jointly develop world-course cloud computing-powered technological answers to benefit local ICT businesses.